---
title: "以嶺藥業的子公司獲得中國批准生產阿爾茨海默病藥物的原材料"
description: "以嶺藥業子公司獲得中國對阿爾茨海默病藥物原料的批准"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/265661137.md"
published_at: "2025-11-13T07:35:39.000Z"
---

# 以嶺藥業的子公司獲得中國批准生產阿爾茨海默病藥物的原材料

> 以嶺藥業子公司獲得中國對阿爾茨海默病藥物原料的批准

### Related Stocks

- [002603.CN - 以嶺藥業](https://longbridge.com/zh-HK/quote/002603.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Yiling Pharmaceutical Withdraws Drug Registration Application for Chaihuang Lidan Capsules | Yiling Pharmaceutical Withdraws Drug Registration Application for Chaihuang Lidan Capsules | [Link](https://longbridge.com/zh-HK/news/267815314.md) |
| Cipla incorporates subsidiary Cipla Middle East Company in Kingdom of Saudi Arabia | Cipla incorporates subsidiary Cipla Middle East Company in Kingdom of Saudi Arabia | [Link](https://longbridge.com/zh-HK/news/277484983.md) |
| Vedanta Named Preferred Bidder for Key Bauxite Block in Odisha | Vedanta Limited has been named the preferred bidder for the Karnapodikonda bauxite block in Odisha after a competitive e | [Link](https://longbridge.com/zh-HK/news/277228297.md) |
| Iran says Natanz nuclear site hit in US-Israeli strikes | VIENNA, March 2 (Reuters) - Iran’s sprawling nuclear facility at Natanz was struck during U.S. and Israeli military oper | [Link](https://longbridge.com/zh-HK/news/277439412.md) |
| No sign that Iran's nuclear sites hit, cannot reach Iranian authorities, IAEA says | The International Atomic Energy Agency (IAEA) reported no evidence that recent attacks by Israel and the U.S. have impac | [Link](https://longbridge.com/zh-HK/news/277433521.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。